NEC Risk Reduced in 2nd Clinical Study Using 100% Human Milk Diet for Preemies

This week, Prolacta Bioscience announced a new clinical study just published by the Journal of Pediatrics clearly demonstrating that 100% exclusive human milk based diet for pre-term infants reduces chances of surgery associated with the life threatening disease necrotizing enterocolitis (NEC).  This reinforces a study in 2009 and points to a new standard of care for these infants.

Even ...

Continue Reading →

BayCare Health Systems & Prolacta Bioscience Set Pace for Premature Infant 100% Breastmilk Diet

Partnership with Prolacta Bioscience (PilmerPR client) Ensures a Safe, Standardized, and Steady Supply of Pasteurized Donor Milk to Meet Feeding Needs of Premature Infants throughout BayCare Health System

CLEARWATER, Fla., July 11, 2013 /PRNewswire-USNewswire/ — BayCare Health System has announced a partnership with Prolacta Bioscience to ensure a safe, standardized, and steady supply of pasteurized donor breast milk to meet the feeding requirements of their hospitalized premature infant population. Under the partnership, Prolacta will manage the breast milk donor qualification ...

Continue Reading →

CSR PR a Mandate for Prolacta

Working with clients focused on corporate social responsibility public relations (CSR PR) makes me feel good. Here is an awesome announcement from our client Prolacta that makes me think we are making a difference for good.

Prolacta Bioscience has announced that more than one million dollars (USD$1,000,000) has been donated to various charitable organizations over the past five years.  Prolacta’s contributions ...

Continue Reading →